CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6932 result(s)

Non-Pharmacological Interventions for Chronic Non-Cancer Pain: Physical Activity

Event Date: September 23, 2020
Result type: Events

Because of the prevalence and burden of chronic pain, health care providers are in search of the best multifaceted approach for treatment knowing that relying on opioids alone can be ineffective and carries substantial risks. Join CADTH for a webinar on the current evidence on physical activity for chronic, non-cancer pain. The target audience f...

Blood Plasma Therapies For COVID-19

Event Date: August 25, 2020
Result type: Events

With the COVID-19 pandemic showing no signs of slowing down, there’s a lot of interest in the global effort to develop a vaccine. Below the radar, researchers are exploring many other treatment options, including a century-old therapy that has been used to combat outbreaks of polio, measles, mumps, and influenza. Convalescent plasma therapy, whi...

nintedanib (Ofev)

Last Updated: August 14, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: nintedanib
Indications: chronic fibrosing interstitial lung diseases

  • Brand Name: Ofev
  • Manufacturer: Boehringer Ingelheim (Canada) Ltd.
  • Project Number: SR0654-000
  • Project Status: Active
  • Submission Type: New

etonogestrel (Nexplanon)

Last Updated: August 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: etonogestrel
Indications: Prevention of pregnancy

  • Brand Name: Nexplanon
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0648-000
  • Project Status: Active
  • Submission Type: New

vedolizumab (Entyvio)

Last Updated: August 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vedolizumab
Indications: Crohn’s disease

  • Brand Name: Entyvio
  • Manufacturer: Takeda Canada Inc.
  • Project Number: SR0647-000
  • Project Status: Active
  • Submission Type: New

ustekinumab (Stelara/Stelara I.V)

Last Updated: August 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New

icosapent ethyl (Vascepa)

Last Updated: August 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: icosapent ethyl
Indications: Ischemic events in statin-treated patients

  • Brand Name: Vascepa
  • Manufacturer: HLS Therapeutics
  • Project Number: SR0619-000
  • Project Status: Active
  • Submission Type: New

Models of Care for Chronic Pain: An Environmental Scan

Last Updated: August 14, 2020
Result type: Reports
Product Line: Environmental Scans

Chronic pain affects approximately 19% of adults in Canada, which results in substantial physical and psychological morbidity and costs to the health care system. CADTH is undertaking an Environmental Scan to help inform the development of strategies and programs to respond to the care needs of Canadians affected by chronic pain. The key object...

  • Project Number: ES0350-000